Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives

Go back to Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Illumina, Inc. (NASDAQ: ILMN) Delayed: 282.86 +14.93 (5.57%)
Previous Close $267.93    52 Week High $196.47 
Open $267.35    52 Week Low $127.10 
Day High $286.40    P/E 314.29 
Day Low $263.28    EPS $0.90 
Volume 2,271,390       

Laboratory Corp. of America Holding (NYSE: LH) Delayed: 323.75 +0.62 (0.19%)
Previous Close $323.13    52 Week High $141.32 
Open $319.10    52 Week Low $97.79 
Day High $325.00    P/E 51.80 
Day Low $317.71    EPS $6.25 
Volume 566,729       

Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 5.57 +0.03 (0.54%)
Previous Close $5.54    52 Week High $45.34 
Open $5.60    52 Week Low $15.92 
Day High $5.74    P/E 2.39 
Day Low $5.45    EPS $2.33 
Volume 4,951,510